Docosahexaenoic acid inhibited the Wnt/β-Catenin pathway and suppressed breast cancer cells in vitro and in vivo

Journal of Nutritional Biochemistry

Volumn 25, Issue 2, 2014, Pages 104-110

  Xue, Meilan ^a   Wang, Qing ^a   Zhao, Jinglan ^b   Dong, Liyan ^c   Ge, Yinlin ^a   Hou, Lin ^a   Liu, Yongchao ^a   Zheng, Zheng ^a  

^a QINGDAO UNIVERSITY   (China)

^b Qingdao Center Medical Group   (China)

^c SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

catenin; Breast cancer; Docosahexaenoic acid; Fish oil; Tumor bearing mouse; Wnt signaling

Indexed keywords

BETA CATENIN; CYCLIN D1; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

ANIMALIA; MUS;

BREAST CANCER; DOCOSAHEXAENOIC ACID; FISH OIL; TUMOR-BEARING MOUSE; WNT SIGNALING; Β-CATENIN;

ANIMALS; APOPTOSIS; BETA CATENIN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; HUMANS; MICE; WNT PROTEINS;

EID: 84892546031     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.09.008     Document Type: Article

References (36)

1. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999, 9(1):15-21.
2. Behrens J. Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci 2000, 910:21-33.
3. Cowin P., Rowlands T.M., Hatsell S.J. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005, 17(5):499-508.
4. Kikuchi A., Yamamoto H., Kishida S. Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal 2007, 19(4):659-671.
5. MacDonald B.T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009, 17(1):9-26.
6. Holland J.D., Klaus A., Garratt A.N., Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 2013, S0955-0674(13):5-7.
7. Turashvili G., Bouchal J., Burkadze G., Kolar Z. Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 2006, 73(5):213-223.
8. Verras M., Sun Z. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 2006, 237(1):22-32.
9. Bartram H.P., Gostner A., Scheppach W., Reddy B.S., Rao C.V., Dusel G., et al. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2, release in healthy subjects. Gastroenterology 1993, 105(5):1317-1322.
10. Laviano A., Rianda S., Molfino A., Fanelli F.R. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care 2013, 16:156-161.
11. Siegel G., Ermilov E. Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases. Atherosclerosis 2012, 225(2):291-295.
12. Chapkin R.S., McMurray D.N., Lupton J.R. Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 2007, 23(1):48-54.
13. Larsson S.C., Kumlin M., Ingelman-Sundberg M., Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004, 79(6):935-945.
14. Sauer L.A., Blask D.E., Dauchy R.T. Dietary factors and growth and metabolism in experimental tumors. Nutr Biochem 2007, 18(10):637-649.
15. Cavazos D.A., Price R.S., Apte S.S., deGraffenried L.A. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. Prostate 2011, 71(13):1420-1428.
16. Collett E.D., Davidson L.A., Fan Y.Y., Lupton J.R., Chapkin R.S. N-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 2001, 280(5):C1066-C1075.
17. McCarty M.F. Fish oil may impede tumour angiogenesis and invasiveness by downregulating protein kinase C and modulating eicosanoid production. Med Hypotheses 1996, 46(2):107-115.
18. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 1987, 47(4):943-946.
19. Kang D.W., Min G., Park do Y., Hong K.W., Min do S. Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells. Exp Mol Med 2010, 42(8):555-564.
20. Lin Y.H., Salem N. Whole body distribution of deuterated linoleic acid and alpha-linolenic acids and their metabolites in the rat. J Lipid Res 2007, 48(12):2709-2724.
21. Zhang X., Deng H.X., Zhao X., Su D., Chen X.C., Chen L.J., et al. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo. Oncology 2009, 77(1):22-32.
22. Siddiqui R.A., Jenski L.J., Neff K., Harvey K., Kovacs R.J., Stillwell W. Docosahexanoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process. Biochim Biophys Acta 2001, 1499(3):265-275.
23. Sun H., Berquin I.M., Owens R.T., O'Flaherty J.T., Edwards I.J. Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res 2008, 68(8):2912-2919.
24. Sauer L.A., Dauchy R.T., Blask D.E., Krause J.A., Davidson L.K., Dauchy E.M. Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J Nutr 2005, 135(9):2124-2129.
25. Karim R., Tse G., Putti T., Scolyer R., Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004, 36(2):120-128.
26. Brown A.M. Wnt signaling in breast cancer: have we come full circle?. Breast Cancer Res 2001, 3(6):351-355.
27. Morrell N.T., Leucht P., Zhao L., Kim J.B., ten Berge D., Ponnusamy K., Carre A.L., Dudek H., Zachlederova M., McElhaney M., Brunton S., Gunzner J., Callow M., Polakis P., Costa M., Zhang X.M., Helms J.A., Nusse R. Liposomal packaging generates Wnt protein with in vivo biological activity. PLoS One 2008, 3(8):e2930.
28. Barker N., Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006, 5(12):997-1014.
29. Xu W.L., Wang Q., Du M., Zhao Y.H., Sun X.R., Sun W.G., et al. Growth inhibition effect of beta-catenin small interfering RNA-mediated gene silencing on human colon carcinoma HT-29 cells. Cancer Biother Radiopharm 2010, 25(5):529-537.
30. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 2000, 97(8):4262-4266.
31. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281(5382):1509-1512.
32. Gough N.R. Focus issue: Wnt and β-catenin signaling in development and disease. Sci Signal 2012, 5(206):eg2.
33. Huber A.H., Weis W.I. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 2001, 105(3):391-402.
34. Vita M., Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 2006, 16(4):318-330.
35. Sherr C.J. Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians 1995, 107(2):181-186.
36. Bose S., Chandran S., Mirocha J.M., Bose N. The Akt pathway in human breast cancer: a tissue-array-based analysis. Mod Pathol 2006, 19(2):238-245.